Bcl-2 is a prognostic marker and its silencing inhibits recurrence in ameloblastomas.

MLA

Kim, Jue Young, et al. “Bcl-2 Is a Prognostic Marker and Its Silencing Inhibits Recurrence in Ameloblastomas.” Oral Diseases, vol. 25, no. 4, May 2019, pp. 1158–68. EBSCOhost, https://doi.org/10.1111/odi.13070.

APA

Kim, J. Y., Kim, J., Bazarsad, S., Cha, I.-H., Cho, S.-W., & Kim, J. (2019). Bcl-2 is a prognostic marker and its silencing inhibits recurrence in ameloblastomas. Oral Diseases, 25(4), 1158–1168. https://doi.org/10.1111/odi.13070

Chicago

Kim, Jue Young, Jinsun Kim, Shadavlonjid Bazarsad, In-Ho Cha, Sung-Won Cho, and Jin Kim. 2019. “Bcl-2 Is a Prognostic Marker and Its Silencing Inhibits Recurrence in Ameloblastomas.” Oral Diseases 25 (4): 1158–68. doi:10.1111/odi.13070.